Xenon Pharmaceuticals Inc.
XENE
|
$41.37
0.17%
0.17%
360K
|
Health Technology
(0.0% 1d) (-3.7% 1m) (11.5% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (-37.84% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 3,120,641,780
http://www.xenon-pharma.com
Sec Filling | Patents | 104 employees
(CA) Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
nervous system neurological
add to watch list Paper trade email alert is off
Press-releases
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: -1.05%
H: 1.69%
C: -0.35%
conference pharmaceuticals
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: -0.4%
H: 1.57%
C: 0.5%
conference pharmaceuticals
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: 0.34%
H: 1.7%
C: 1.53%
pharmaceuticals
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: 0.0%
H: 3.13%
C: -0.09%
conference biopharma pharmaceuticals global
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: 5.3%
H: 2.6%
C: -5.75%
year update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: -0.08%
H: 0.61%
C: 0.51%
conference year update pharmaceuticals financial results
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: -0.53%
H: 6.05%
C: 5.79%
pharmaceuticals key milestone
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: -0.47%
H: 0.47%
C: -1.14%
conference pharmaceuticals
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
|
| O: 0.4%
H: 2.35%
C: 2.19%
offering pharmaceuticals
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
Published: 2023-12-02 (Crawled : 20:20) - globenewswire.com
XENE | $41.37 0.17% 0.17% 360K
|
Health Technology
| Email alert
Add to watchlist
FNCTF | $11.128 -20.84% 580
|
Communications
| Email alert
Add to watchlist
pipeline pharmaceuticals meeting
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Last 48 Hours Insiders Buying
RMCF | $3.56 -7.2% 7.1K
|
Consumer Non-Durables
|
20:10